Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Trogocytosis is a gateway to characterize functional diversity in melanoma-specific CD8+ T cell clones.
Uzana R, Eisenberg G, Sagi Y, Frankenburg S, Merims S, Amariglio N, Yefenof E, Peretz T, Machlenkin A, Lotem M.
J Immunol. 2012 Jan 15;188(2):632-40. Epub 2011 Dec 7.
Related citations
Regulatory role of Vγ1 γδ T cells in tumor immunity through IL-4 production.
Hao J, Dong S, Xia S, He W, Jia H, Zhang S, Wei J, O'Brien RL, Born WK, Wu Z, Wang P, Han J, Hong Z, Zhao L, Yin Z.
J Immunol. 2011 Nov 15;187(10):4979-86. Epub 2011 Oct 10.
Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody.
Garrido G, Rabasa A, Sánchez B, López MV, Blanco R, López A, Hernández DR, Pérez R, Fernández LE.
J Immunol. 2011 Nov 15;187(10):4954-66. Epub 2011 Oct 7.
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.
Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R, Ménoret A, Mittler RS, Gordon SM, Reiner SL, Vella AT, Adler AJ.
J Immunol. 2011 Oct 1;187(7):3555-64. Epub 2011 Aug 31.
Novel highly sensitive IL-10-beta-lactamase reporter mouse reveals cells of the innate immune system as a substantial source of IL-10 in vivo.
Bouabe H, Liu Y, Moser M, Bösl MR, Heesemann J.
J Immunol. 2011 Sep 15;187(6):3165-76. Epub 2011 Aug 15.
Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
Roda JM, Sumner LA, Evans R, Phillips GS, Marsh CB, Eubank TD.
J Immunol. 2011 Aug 15;187(4):1970-6. Epub 2011 Jul 15.
CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma.
Qian J, Yi H, Guo C, Yu X, Zuo D, Chen X, Kane JM 3rd, Repasky EA, Subjeck JR, Wang XY.
J Immunol. 2011 Sep 15;187(6):2905-14. Epub 2011 Aug 10.
Lentivector prime and vaccinia virus vector boost generate high-quality CD8 memory T cells and prevent autochthonous mouse melanoma.
Xiao H, Peng Y, Hong Y, Liu Y, Guo ZS, Bartlett DL, Fu N, He Y.
J Immunol. 2011 Aug 15;187(4):1788-96. Epub 2011 Jul 11.
MyD88-dependent TLR1/2 signals educate dendritic cells with gut-specific imprinting properties.
Wang S, Villablanca EJ, De Calisto J, Gomes DC, Nguyen DD, Mizoguchi E, Kagan JC, Reinecker HC, Hacohen N, Nagler C, Xavier RJ, Rossi-Bergmann B, Chen YB, Blomhoff R, Snapper SB, Mora JR.
J Immunol. 2011 Jul 1;187(1):141-50. Epub 2011 Jun 6.
Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
Iwata-Kajihara T, Sumimoto H, Kawamura N, Ueda R, Takahashi T, Mizuguchi H, Miyagishi M, Takeda K, Kawakami Y.
J Immunol. 2011 Jul 1;187(1):27-36. Epub 2011 Jun 1.
Rescue of tumor-infiltrating lymphocytes from activation-induced cell death enhances the antitumor CTL response in CD5-deficient mice.
Tabbekh M, Franciszkiewicz K, Haouas H, Lécluse Y, Benihoud K, Raman C, Mami-Chouaib F.
J Immunol. 2011 Jul 1;187(1):102-9. Epub 2011 May 27.
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, Koernig S, Morelli AB, Clausen BE, Dauer M, Eigler A, Anz D, Bourquin C, Maraskovsky E, Endres S, Schnurr M.
J Immunol. 2011 Jul 1;187(1):55-63. Epub 2011 May 25.
The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function.
Ramachandran IR, Song W, Lapteva N, Seethammagari M, Slawin KM, Spencer DM, Levitt JM.
J Immunol. 2011 Apr 1;186(7):3934-45. Epub 2011 Feb 25.
IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer.
Kryczek I, Wu K, Zhao E, Wei S, Vatan L, Szeliga W, Huang E, Greenson J, Chang A, Roliński J, Radwan P, Fang J, Wang G, Zou W.
J Immunol. 2011 Apr 1;186(7):4388-95. Epub 2011 Feb 28.
MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.
Hemon P, Jean-Louis F, Ramgolam K, Brignone C, Viguier M, Bachelez H, Triebel F, Charron D, Aoudjit F, Al-Daccak R, Michel L.
J Immunol. 2011 May 1;186(9):5173-83. Epub 2011 Mar 25.
Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model.
Lisiero DN, Soto H, Liau LM, Prins RM.
J Immunol. 2011 May 1;186(9):5068-77. Epub 2011 Mar 23.
Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.
Soderquest K, Walzer T, Zafirova B, Klavinskis LS, Polić B, Vivier E, Lord GM, Martín-Fontecha A.
J Immunol. 2011 Mar 15;186(6):3304-8. Epub 2011 Feb 9.
Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis.
Carmi Y, Rinott G, Dotan S, Elkabets M, Rider P, Voronov E, Apte RN.
J Immunol. 2011 Mar 15;186(6):3462-71. Epub 2011 Feb 7.
IL-10 controls cystatin C synthesis and blood concentration in response to inflammation through regulation of IFN regulatory factor 8 expression.
Xu Y, Schnorrer P, Proietto A, Kowalski G, Febbraio MA, Acha-Orbea H, Dickins RA, Villadangos JA.
J Immunol. 2011 Mar 15;186(6):3666-73. Epub 2011 Feb 7.
CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions.
Seth S, Oberdörfer L, Hyde R, Hoff K, Thies V, Worbs T, Schmitz S, Förster R.
J Immunol. 2011 Mar 15;186(6):3364-72. Epub 2011 Feb 4.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on